BlueRock Therapeutics

BlueRock Therapeutics

生物技术研究

Cambridge,Massachusetts 65,244 位关注者

Striving to transform the treatment of disease by harnessing the power of cell therapy

BlueRock's Approach

Pluripotent stem cells (PSCs) are blank canvas cells that have the potential to become any cell type in the body. Using our cell+gene platform, we take fully developed adult cells, such as blood cells, from healthy donors and turn them back into their blank canvas state, resulting in cells known as induced pluripotent stem cells (iPSCs).

Learn More

The Parkinson's Disease Landscape

The standard of care for Parkinson’s disease has seen nominal improvement in the last 60 years. WE’RE WORKING TO CHANGE THAT.

Learn more

相似主页

查看职位